Ionis Pharmaceuticals SG&A Expense (TTM) Analysis

Ionis Pharmaceuticals Inc (IONS)

37.60 +1.05 (+2.87%) USD | NASDAQ | May 31, 16:00

37.58 -0.02 (-0.04%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1991. Upgrade now.

Date	Value
March 31, 2024	239.74M
December 31, 2023	232.62M
September 30, 2023	209.52M
June 30, 2023	173.92M
March 31, 2023	161.62M
December 31, 2022	150.23M
September 30, 2022	140.93M
June 30, 2022	136.63M
March 31, 2022	147.93M
December 31, 2021	170.90M
September 30, 2021	249.00M
June 30, 2021	287.30M
March 31, 2021	314.22M
December 31, 2020	332.12M
September 30, 2020	298.69M
June 30, 2020	290.33M
March 31, 2020	293.42M
December 31, 2019	286.64M
September 30, 2019	269.43M
June 30, 2019	278.10M
March 31, 2019	269.19M
December 31, 2018	244.62M
September 30, 2018	224.27M
June 30, 2018	182.34M
March 31, 2018	138.46M

Date	Value
December 31, 2017	108.49M
September 30, 2017	80.82M
June 30, 2017	64.22M
March 31, 2017	51.73M
December 31, 2016	48.62M
September 30, 2016	43.76M
June 30, 2016	42.32M
March 31, 2016	40.27M
December 31, 2015	37.17M
September 30, 2015	30.82M
June 30, 2015	26.54M
March 31, 2015	23.22M
December 31, 2014	20.14M
September 30, 2014	17.99M
June 30, 2014	16.95M
March 31, 2014	15.88M
December 31, 2013	14.92M
September 30, 2013	13.48M
June 30, 2013	13.14M
March 31, 2013	12.96M
December 31, 2012	12.52M
September 30, 2012	13.08M
June 30, 2012	13.09M
March 31, 2012	12.76M
December 31, 2011	12.79M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

136.63M

Minimum

Jun 2022

332.12M

Maximum

Dec 2020

233.16M

Average

244.37M

Median

SG&A Expense (TTM) Benchmarks